Presentation is loading. Please wait.

Presentation is loading. Please wait.

Diffusion MRI is sensitive to brain tumor cell density Clinical ADC and cell density are negatively correlated (Sugahara, 1999; Lyng, 2000; Chenevert,

Published byMercy Gaines Modified over 9 years ago

Similar presentations

Presentation on theme: "Diffusion MRI is sensitive to brain tumor cell density Clinical ADC and cell density are negatively correlated (Sugahara, 1999; Lyng, 2000; Chenevert,"— Presentation transcript:

1 Diffusion MRI is sensitive to brain tumor cell density Clinical ADC and cell density are negatively correlated (Sugahara, 1999; Lyng, 2000; Chenevert, 2000; Gaurain, 2001; Nonomura, 2001; Guo, 2002; Chen, 2005; Hayashida, 2006; Manenti, 2008; Kinoshita, 2008)  ADC (or mean diffusion) =  cell density (“hypercellularity”)  ADC =  cell density (“hypocellularity”) Viable Tumor (Dark) Necrotic Core Edema ADC Map B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010

2 Diffusion MRI is sensitive to brain tumor cell density Tests at our laboratory have confirmed this relationship - 17 glioma patients (WHO II-IV) underwent diagnostic stereotactic biopsy - Biopsy sites were spatially matched to pre-operative ADC maps R 2 = 0.7933; P < 0.001 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009From: Ellingson, et al. JMRI 2009, In Press

3 The Functional Diffusion Map (fDM) (Moffat, 2005; 2006; Hamstra, 2005; 2008) B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 From: Ellingson, JMRI, 2009, In Press

4 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2009 SNO/CNS 2009 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010

5 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2009 SNO/CNS 2009 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010From: Ellingson et al. J Neurooncol, 2009, In Press

6 Early Detection of Brain Tumor Growth T1+C FLAIR fDMs B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Hypercellular Regions (Blue) Contrast-Enhancement (white)

7 fDMs in Brain Tumor Progression B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 T1+C FLAIR fDM 3 mo.6 mo.9 mo. (Onset of symptoms)

8 B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009 fDMs in Progressive Disease (PD)  Hypercellularity

9 fDM Results in Stable Disease (SD) Treatment: Radiation + Temozolomide B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009

10 Treatment: Radiation + Temozolomide fDM Results in Responding Disease (RD) B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009

11 fDM Results in Stable/Responding Disease (SD/RD) B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009  Hypocellularity

12 fDMs are an early biomarker for cytotoxic and new anti-angiogenic treatments B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Ellingson BM, J Neurooncol, Under Prep

13 Results B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009 “fDM Responders” have significantly longer TTP after standard Tx –fDMs are a better predictor than tumor grade

14 Results B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 SNO/CNS 2009 “fDM Responders” have significantly longer survival on bevacizumab –fDMs are better predictors than grade, age, or mono/combined therapy

15 Graded fDMs Allow Visualization of Growing Tumor B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 + Hypercellular+ Hypocellular 1 Mo.2 Mo.3 Mo.4 Mo.

16 Graded fDMs Allow Visualization of Growing Tumor B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 + Hypercellular+ Hypocellular 7 Mo.5 Mo. 3 Mo.

17 Graded fDMs Allow Visualization of Growing Tumor B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 + Hypercellular+ Hypocellular 5 Mo.4 Mo. 2 Mo.

18 Hypercellular Hypocellular Macrophages & Inflammatory Cells Demyelination Graded fDMs in Demyelination B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Biopsy Diagnosis = Demyelination (Multiple Sclerosis) 3 Mo.5 Mo.7 Mo.9 Mo.

19 Graded fDMs: Radiation Necrosis vs. Tumor B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Hypercellular Hypocellular T1+C FLAIR Graded fDM

20 Graded fDMs: Radiation Induced Changes B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Hypercellular Hypocellular 2 Mo.3 Mo.5 Mo. 8 Mo. 14 Mo. 18 Mo.21 Mo. 23 Mo.

21 Graded fDMs: Radiation Induced Changes B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Hypercellular Hypocellular 2 Mo. 4 Mo. 6 Mo. 10 Mo. 14 Mo. 18 Mo.

22 Graded fDMs Improve Tumor Localization/Grading in Stereotactic Needle Biopsy B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010

23 Graded fDMs Improve Tumor Localization and Grading in Stereotactic Needle Biopsy B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 2 Lesions Biopsy (WHO II) Hypercellular Hypocellular

24 Graded fDMs Improve Tumor Localization for Resection B.M. Ellingson, Ph.D., Dept. of Radiology, Medical College of Wisconsin, 2010 Hypercellular Hypocellular Resection Cavity Only 10% of Hypercellular regions were removed!

Download ppt "Diffusion MRI is sensitive to brain tumor cell density Clinical ADC and cell density are negatively correlated (Sugahara, 1999; Lyng, 2000; Chenevert,"

Similar presentations

Case Study 52 Edward D. Plowey. Case History The patient is a 48 year old woman with a 3-year history of migraine headaches and recent development of.

Case Study 52 Edward D. Plowey. Case History The patient is a 48 year old woman with a 3-year history of migraine headaches and recent development of.
A Proposal for BMS-354825 (Dasatinib) in GIST Jon Trent, MD, PhD Assistant Professor Dept. of Sarcoma Medical Oncology The University of Texas, M. D. Anderson.

A Proposal for BMS (Dasatinib) in GIST Jon Trent, MD, PhD Assistant Professor Dept. of Sarcoma Medical Oncology The University of Texas, M. D. Anderson.
A. HRICHI, S. KOUKI, M. LANDOULSI,R. AOUINI, I. GANZOUI, S.BOUGUERRA, Y. AROUS, H. BOUJEMAA, N. BEN ABDALLAH Radiology service, Main Military hospital.

A. HRICHI, S. KOUKI, M. LANDOULSI,R. AOUINI, I. GANZOUI, S.BOUGUERRA, Y. AROUS, H. BOUJEMAA, N. BEN ABDALLAH Radiology service, Main Military hospital.
Advanced NSCLC Objective response rate -Well defined & widely accepted -Does not correlate well with OS -May be more useful if SD included -Higher RR correlates.

Advanced NSCLC Objective response rate -Well defined & widely accepted -Does not correlate well with OS -May be more useful if SD included -Higher RR correlates.
B.M. Ellingson 1,2, M.G. Malkin 1,3,4, S.D. Rand 1,2, J.M. Connelly 3, C. Quinsey 4 P.S. LaViolette 1,5, D.P. Bedekar 1,2, and K.M. Schmainda 1,2,5 B.M.

B.M. Ellingson 1,2, M.G. Malkin 1,3,4, S.D. Rand 1,2, J.M. Connelly 3, C. Quinsey 4 P.S. LaViolette 1,5, D.P. Bedekar 1,2, and K.M. Schmainda 1,2,5 B.M.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.

In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Functional Diffusion Maps (fDMs) for Brain Tumor Treatment Response Monitoring Benjamin M. Ellingson, Ph.D. Assistant Professor of Radiology Dept. of Radiological.

Functional Diffusion Maps (fDMs) for Brain Tumor Treatment Response Monitoring Benjamin M. Ellingson, Ph.D. Assistant Professor of Radiology Dept. of Radiological.
Methods to Differentiate Radiation Induced Necrosis and Recurrent Disease in Gliomas Lars Ewell University of Arizona Medical Center Department of Radiation.

Methods to Differentiate Radiation Induced Necrosis and Recurrent Disease in Gliomas Lars Ewell University of Arizona Medical Center Department of Radiation.
Stereotactic Radiosurgery Jimmy Johannes Physics 335 – Spring 2004 Final Presentation

Stereotactic Radiosurgery Jimmy Johannes Physics 335 – Spring 2004 Final Presentation
ENHANCING DETECTION.... YOUR PRACTICE.

ENHANCING DETECTION.... YOUR PRACTICE.
HKS Tumore HKS Tumore Epigenetics in glioma - MGMT, ABCB1 and ABCG2 methylation in glioma Moritz C. Oberstadt, PhD.

HKS Tumore HKS Tumore Epigenetics in glioma - MGMT, ABCB1 and ABCG2 methylation in glioma Moritz C. Oberstadt, PhD.
DegenerationRegeneration Traumatic Injury Degenerative Disease Radiation/Chemotherapy Brain Tumors Stem Cells & Regenerative Medicine B.M. Ellingson, Ph.D.,

DegenerationRegeneration Traumatic Injury Degenerative Disease Radiation/Chemotherapy Brain Tumors Stem Cells & Regenerative Medicine B.M. Ellingson, Ph.D.,
Brain Tumors Maria Rountree. Most common types of brain tumors The most common childhood tumors are: The most common childhood tumors are: 1. Astrocytoma.

Brain Tumors Maria Rountree. Most common types of brain tumors The most common childhood tumors are: The most common childhood tumors are: 1. Astrocytoma.
Lecturer of Medical-Surgical

Lecturer of Medical-Surgical
Taylor J Greenwood, MD, Adam Wallace, MD, Aseem Sharma, MD, Jack Jennings, MD, PhD.

Taylor J Greenwood, MD, Adam Wallace, MD, Aseem Sharma, MD, Jack Jennings, MD, PhD.
Imaging of bevacizumab treated brain: traditional and emerging concepts Asim K. Bag Joel K Cure Aparna Singhal David Wever Asim K. Bag Joel K Cure Aparna.

Imaging of bevacizumab treated brain: traditional and emerging concepts Asim K. Bag Joel K Cure Aparna Singhal David Wever Asim K. Bag Joel K Cure Aparna.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.

Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.

Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.
Living Beyond Breast Cancer Liver and Lung Metastases Workshop April 29, 2012 Paul B. Gilman, MDLankenau Medical Center.

Living Beyond Breast Cancer Liver and Lung Metastases Workshop April 29, 2012 Paul B. Gilman, MDLankenau Medical Center.
Case Study 50 Edward D. Plowey. Case History The patient is a 2 year old girl with normal birth and developmental histories who presented with new onset.

Case Study 50 Edward D. Plowey. Case History The patient is a 2 year old girl with normal birth and developmental histories who presented with new onset.

Similar presentations

Ads by Google